pharma Are Cancer Drug Price Cuts the Worst for Patients? October 30, 2026 Vincent Hughes Cancer drug price cuts fail to deliver real benefits to patients using expensive brands.
pharma FDA Accelerated Approval: Is Ultomiris the Best Option? October 22, 2026 Vincent Hughes FDA accelerated approval has been granted to Ultomiris for IgAN treatment, offering new hope for patients.
pharma FDA Approval for Liver Cancer Drug: Clear Path Ahead October 15, 2026 Vincent Hughes FDA approval liver cancer drug is anticipated this year as HLB resolves manufacturing issues.
pharma Novo drug launches: Are they the best investment choice? September 21, 2026 Vincent Hughes Novo drug launches are gaining attention as the company seeks to win back investors with innovative solutions.